
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Recursion Pharma
Recursion Pharmaceuticals, Inc. operates as a bio-technology company. The Company combines artificial intelligence with automation to conduct experimental biology for testing compounds of cellular disease models in parallel. Recursion Pharmaceuticals serves customers worldwide.
Stock Analysis

last close
$8.85
1-mo return
23.8%
3-mo return
24.3%
avg daily vol.
1.25M
52-week high
42.81
52-week low
4.92
market cap.
$1.4B
forward pe
-
annual div.
-
roe
-164.1%
ltg forecast
15.9%
dividend yield
-
annual rev.
$13M
inst own.
77%